Tak-438 Powder CAS 1260141-27-2 Chemical Intermediate Vonoprazan Fumarate

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: API
• Certification: GMP, ISO 9001
• Suitable for: All
• State: Solid
• Purity: >99%
• Keyword: Vonoprazan Fumarate
• Sample: Available
• MOQ: Consult
• Mf: C21h20fn3o6s
• CAS: 1260141-27-2
• Test Method: HPLC
• Transport Package: Aluminum Foil Bag/Paper Drum
• Specification: 99%
• Trademark: xinlu
• Origin: China
• Production Capacity: 100kg

Product Description

 

TAK-438 is a novel, orally bioavailable small molecule inhibitor that targets a specific pathway or protein involved in cellular signaling or disease progression. It is under investigation for its potential therapeutic applications in various medical conditions.

 

 

Product Name	TAK-438
Appearance	White Powder
CAS NO.	1260141-27-2
Molecular Formula	C21h20fn3o6s
Storage	Keep in a cool, dry, dark location

1. Inhibition of Cellular Signaling Pathways: TAK-438 functions by inhibiting specific protein kinases or other enzymes involved in cellular signaling pathways that are implicated in disease progression.
2. Modulation of Gene Expression: In some instances, TAK-438 may also affect gene expression patterns, leading to changes in the production of proteins that contribute to disease development.
3. Enhancement of Therapeutic Effects: By targeting key pathways or proteins, TAK-438 may enhance the therapeutic effects of other medications or treatment modalities, leading to improved patient outcomes.

1. Cancer Therapy: TAK-438 is being studied as a potential treatment for various types of cancer, including solid tumors and hematological malignancies, due to its ability to inhibit specific oncogenic pathways.
2. Inflammatory Diseases: The compound is also being explored for its potential to reduce inflammation and ameliorate symptoms in inflammatory diseases such as rheumatoid arthritis, psoriasis, and inflammatory bowel disease.
3. Neurological Disorders: Preliminary studies suggest that TAK-438 may have therapeutic benefits in certain neurological disorders, including Alzheimer's disease, Parkinson's disease, and multiple sclerosis, by modulating neuronal signaling pathways.

Related products

Product Name	CAS No.	Product Name	CAS No.
Lufenuron	103055-07-8	Toltrazuril	69004-03-1
Nitenpyram	120738-89-8	Praziquantel/Biltricide	55268-74-1
Fenbendazole	43210-67-9	Tetramisole Hcl	5086-74-8
Levamisole	14769-73-4	Ponazuril	9004-4-2
Diclazuril	101831-37-2	Florfenicol	73231-34-2
Albendazole	54965-21-8	Mebendazole	31431-39-7
Ivermectin	70288-86-7	Enrofloxacin Hcl	112732-17-9
RU 58841	154992-24-2	cb-03-01	19608-29-8
Biotin	58-85-5	Biotinoyl tripeptide-1	299157-54-3
Finasteride	98319-26-7	Dutasteride	164656-23-9

Xi'an Xinlu Biotechnology Co., Ltd. is a high-end brand company focusing on the biomedical industry and integrating R&D, production and sales.  It has an independent R&D center, advanced laboratory equipment and a professional R&D team, a GMP standard production workshop, a complete set of internationally advanced assembly line equipment, a preparation workshop with a cleanliness level of 100,000, as well as sophisticated testing instruments and scientific testing methods, providing solid technical support for the production of high-quality products.  Through long-term R&D, production, and sales practices, it has formed its own unique product line, providing users with products of reliable quality at highly affordable prices.  We strictly control quality, ensure the stability of product quality in all aspects, and win the trust of customers with high quality and high-level development.